Iptakalim ameliorates MPP+-induced astrocyte mitochondrial dysfunction by increasing mitochondrial complex activity

Shu Zhang1, Jian-Hua Ding, Fang Zhou

  • 1Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu, Peoples Republic of China.

Summary

Iptakalim (IPT) protects astrocytes from MPP+-induced apoptosis by preserving mitochondrial function. It enhances mitochondrial respiration and ATP production, while reducing reactive oxygen species and cytochrome c release, partly via mitochondrial ATP-sensitive potassium channels.

Related Concept Videos